+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mednax Inc (MD) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 58 Pages
  • May 2022
  • GlobalData
  • ID: 4228599
Mednax Inc (MD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights


Mednax Inc (Mednax) is a provider of physician services. The company offers a wide range of neonatal, maternal-fetal, paediatric cardiology and sub-speciality services. It also offers paediatric subspecialty care services such as inpatient care to ill children and services for the treatment of children’s ear, nose, throat, neck, and urinary and genital problems through its paediatric intensivists, hospitalists, surgeons, urologists, ENT physicians, ophthalmologists and advanced nurse practitioners. The expert clinicians of Mednax collaborate with health care partners to provide customized solutions to hospitals and patients. The company has a presence in the US and in Puerto Rico through its affiliated professional corporations. Mednax is headquartered in Sunrise, Florida, the US.

Mednax Inc Key Recent Developments

  • May 18, 2022: Mednax Announces Leadership Appointments
  • Apr 28, 2022: Mednax Reports First Quarter Results
  • Feb 17, 2022: Mednax Reports Fourth Quarter Results
  • Nov 19, 2021: Mednax to Present at Bank of America 2021 Leveraged Finance Conference
  • Nov 10, 2021: Mednax to Present at Credit Suisse 30th Annual Healthcare Conference

Key benefits of buying this profile include:

  • You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Mednax Inc - Key Facts
  • Mednax Inc - Key Employees
  • Mednax Inc - Key Employee Biographies
  • Mednax Inc - Major Products and Services
  • Mednax Inc - History
  • Mednax Inc - Company Statement
  • Mednax Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 - Company Analysis
  • Company Overview
  • Mednax Inc - Business Description
  • Product Category: Maternal-Fetal Medicine
  • Performance
  • Product Category: Neonatology and Other Pediatric Subspecialties
  • Performance
  • Product Category: Pediatric Cardiology
  • Performance
  • Product Category: Hospital Contract Administration Fee
  • Performance
  • Product Category: Net Patient Service Revenue
  • Performance
  • Product Category: Other Revenue
  • Performance
  • R&D Overview
  • Mednax Inc - Corporate Strategy
  • Mednax Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Mednax Inc - Strengths
  • Mednax Inc - Weaknesses
  • Mednax Inc - Opportunities
  • Mednax Inc - Threats
  • Mednax Inc - Key Competitors

Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Mednax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Mednax Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Mednax Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments
  • May 18, 2022: Mednax Announces Leadership Appointments
  • Apr 28, 2022: Mednax Reports First Quarter Results
  • Feb 17, 2022: Mednax Reports Fourth Quarter Results
  • Nov 19, 2021: Mednax to Present at Bank of America 2021 Leveraged Finance Conference
  • Nov 10, 2021: Mednax to Present at Credit Suisse 30th Annual Healthcare Conference
  • Oct 28, 2021: Mednax Reports Third Quarter Results
  • Oct 13, 2021: Mednax Clinical Leadership Urges Full Vaccination and All Measures to Protect Expecting Mothers and Children During COVID-19 Pandemic
  • Oct 07, 2021: Mednax and Brave Care to accelerate transformation of pediatric primary and urgent care
  • Oct 05, 2021: The Pediatrix and Obstetrix Medical Group reports surge in critically ill pregnant patients with the COVID-19 delta variant
  • Sep 15, 2021: Mednax to Present at Morgan Stanley 19th Annual Global Healthcare Conference

Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact Us
  • Disclaimer

List of Tables
  • Mednax Inc, Key Facts
  • Mednax Inc, Key Employees
  • Mednax Inc, Key Employee Biographies
  • Mednax Inc, Major Products and Services
  • Mednax Inc, History
  • Mednax Inc, Subsidiaries
  • Mednax Inc, Key Competitors
  • Mednax Inc, Ratios based on current share price
  • Mednax Inc, Annual Ratios
  • Mednax Inc, Interim Ratios
  • Mednax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Mednax Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Mednax Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures
  • Mednax Inc, Performance Chart (2017 - 2021)
  • Mednax Inc, Ratio Charts
  • Mednax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Mednax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Community Health Systems Inc
  • Envision Healthcare Corp
  • IPC Healthcare Inc
  • Tivity Health Inc